Literature DB >> 8419134

Impairment of the selenoenzyme type I iodothyronine deiodinase in C3H/He mice.

C H Schoenmakers1, I G Pigmans, A Poland, T J Visser.   

Abstract

Type I iodothyronine deiodinase (ID-I) activity is impaired in C3H/He (C3H) mice compared with BALB/c and C57BL/6N (C57) mice. In this study we compared ID-I activity and protein labeling with N-bromoacetyl(-)[125I]T3 (BrAc[125I]T3) or 75Se in liver microsomes of C3H and C57 mice. Hepatic ID-I activity in C3H mice was highly variable with a median of only 18% of that in C57 mice. However, C3H mice had normal serum T4 and T3 levels, although serum reverse T3 was increased. The 28-kilodalton (kDa) ID-I protein was identified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis of BrAc[125I]T3-labeled microsomes. Labeling of this protein was virtually undetectable in C3H samples with low enzyme activity. ID-I activity in liver microsomes was strongly decreased in Se-deficient mice, which was paralleled by a drastic decrease in BrAc[125I]T3-labeling of the 28-kDa band compared with control mice. Labeling of ID-I with 75Se was demonstrated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis of liver microsomes of [75Se]selenite-injected mice. 75Se labeling of the 28-kDa band was markedly higher in Se-deficient than in control mice and was also markedly higher in C57 than in C3H mice. Finally, liver ID-I messenger RNA (mRNA) was measured on Northern blots using a rat ID-I complementary DNA probe. Messenger RNA levels correlated strongly with ID-I activity, showing a significant decrease in C3H mice. We conclude that in mice, like in rats and humans, ID-I is a selenoprotein. ID-I activity is impaired in C3H mice because of decreased transcription of the ID-I gene or reduced stability of the mRNA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8419134     DOI: 10.1210/endo.132.1.8419134

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  15 in total

1.  Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts.

Authors:  J H Duncan Bassett; Alan Boyde; Peter G T Howell; Richard H Bassett; Thomas M Galliford; Marta Archanco; Holly Evans; Michelle A Lawson; Peter Croucher; Donald L St Germain; Valerie Anne Galton; Graham R Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-05       Impact factor: 11.205

Review 2.  The menace of endocrine disruptors on thyroid hormone physiology and their impact on intrauterine development.

Authors:  George Mastorakos; Eftychia I Karoutsou; Maria Mizamtsidi; George Creatsas
Journal:  Endocrine       Date:  2007-06       Impact factor: 3.633

Review 3.  Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling.

Authors:  Balázs Gereben; Ann Marie Zavacki; Scott Ribich; Brian W Kim; Stephen A Huang; Warner S Simonides; Anikó Zeöld; Antonio C Bianco
Journal:  Endocr Rev       Date:  2008-09-24       Impact factor: 19.871

4.  Sex, genetics, and the control of thyroxine and thyrotropin in mice.

Authors:  Sandra M McLachlan; Sepehr Hamidi; Holly Aliesky; Robert W Williams; Basil Rapoport
Journal:  Thyroid       Date:  2014-05-22       Impact factor: 6.568

Review 5.  Deiodinases: implications of the local control of thyroid hormone action.

Authors:  Antonio C Bianco; Brian W Kim
Journal:  J Clin Invest       Date:  2006-10       Impact factor: 14.808

6.  Differential selenium-dependent expression of type I 5'-deiodinase and glutathione peroxidase in the porcine epithelial kidney cell line LLC-PK1.

Authors:  M Gross; M Oertel; J Köhrle
Journal:  Biochem J       Date:  1995-03-15       Impact factor: 3.857

7.  Physiological and genetic analyses of inbred mouse strains with a type I iodothyronine 5' deiodinase deficiency.

Authors:  M J Berry; D Grieco; B A Taylor; A L Maia; J D Kieffer; W Beamer; E Glover; A Poland; P R Larsen
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

8.  Shared and unique susceptibility genes in a mouse model of Graves' disease determined in BXH and CXB recombinant inbred mice.

Authors:  Sandra M McLachlan; Holly A Aliesky; Pavel N Pichurin; Chun-Rong Chen; Robert W Williams; Basil Rapoport
Journal:  Endocrinology       Date:  2007-12-27       Impact factor: 4.736

Review 9.  The syndrome of inherited partial SBP2 deficiency in humans.

Authors:  Alexandra M Dumitrescu; Caterina Di Cosmo; Xiao-Hui Liao; Roy E Weiss; Samuel Refetoff
Journal:  Antioxid Redox Signal       Date:  2010-04-01       Impact factor: 8.401

10.  Iodothyronine deiodinase enzyme activities in bone.

Authors:  Allan J Williams; Helen Robson; Monique H A Kester; Johannes P T M van Leeuwen; Stephen M Shalet; Theo J Visser; Graham R Williams
Journal:  Bone       Date:  2008-04-04       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.